| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-87 |
Sentence |
denotes |
Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. |
| T1 |
0-87 |
Sentence |
denotes |
Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. |
| TextSentencer_T2 |
88-98 |
Sentence |
denotes |
OBJECTIVE: |
| T2 |
88-98 |
Sentence |
denotes |
OBJECTIVE: |
| TextSentencer_T3 |
99-280 |
Sentence |
denotes |
To characterize a kindred with a familial neurodegenerative disorder associated with a mutation in progranulin (PGRN), with emphasis on the unique clinical features in this kindred. |
| T3 |
99-280 |
Sentence |
denotes |
To characterize a kindred with a familial neurodegenerative disorder associated with a mutation in progranulin (PGRN), with emphasis on the unique clinical features in this kindred. |
| TextSentencer_T4 |
281-288 |
Sentence |
denotes |
DESIGN: |
| T4 |
281-288 |
Sentence |
denotes |
DESIGN: |
| TextSentencer_T5 |
289-388 |
Sentence |
denotes |
Antemortem and postmortem characterization of a kindred with a familial neurodegenerative disorder. |
| T5 |
289-388 |
Sentence |
denotes |
Antemortem and postmortem characterization of a kindred with a familial neurodegenerative disorder. |
| TextSentencer_T6 |
389-397 |
Sentence |
denotes |
SETTING: |
| T6 |
389-397 |
Sentence |
denotes |
SETTING: |
| TextSentencer_T7 |
398-443 |
Sentence |
denotes |
Multispecialty group academic medical center. |
| T7 |
398-443 |
Sentence |
denotes |
Multispecialty group academic medical center. |
| TextSentencer_T8 |
444-453 |
Sentence |
denotes |
PATIENTS: |
| T8 |
444-453 |
Sentence |
denotes |
PATIENTS: |
| TextSentencer_T9 |
454-569 |
Sentence |
denotes |
Affected members of a kindred with dementia with or without parkinsonism associated with a unique mutation in PGRN. |
| T9 |
454-569 |
Sentence |
denotes |
Affected members of a kindred with dementia with or without parkinsonism associated with a unique mutation in PGRN. |
| TextSentencer_T10 |
570-591 |
Sentence |
denotes |
MAIN OUTCOME MEASURE: |
| T10 |
570-591 |
Sentence |
denotes |
MAIN OUTCOME MEASURE: |
| TextSentencer_T11 |
592-623 |
Sentence |
denotes |
Genotype-phenotype correlation. |
| T11 |
592-623 |
Sentence |
denotes |
Genotype-phenotype correlation. |
| TextSentencer_T12 |
624-632 |
Sentence |
denotes |
RESULTS: |
| T12 |
624-632 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T13 |
633-808 |
Sentence |
denotes |
Of 10 affected individuals identified, 6 presented with early amnestic symptoms which resulted in initial diagnoses of Alzheimer disease or amnestic mild cognitive impairment. |
| T13 |
633-808 |
Sentence |
denotes |
Of 10 affected individuals identified, 6 presented with early amnestic symptoms which resulted in initial diagnoses of Alzheimer disease or amnestic mild cognitive impairment. |
| TextSentencer_T14 |
809-892 |
Sentence |
denotes |
Some individuals presented with features characteristic of frontotemporal dementia. |
| T14 |
809-892 |
Sentence |
denotes |
Some individuals presented with features characteristic of frontotemporal dementia. |
| TextSentencer_T15 |
893-1043 |
Sentence |
denotes |
Mean age at onset was substantially younger in generation III (75.8 years; range, 69-80 years) than in generation II (60.7 years; range, 55-66 years). |
| T15 |
893-1043 |
Sentence |
denotes |
Mean age at onset was substantially younger in generation III (75.8 years; range, 69-80 years) than in generation II (60.7 years; range, 55-66 years). |
| TextSentencer_T16 |
1044-1118 |
Sentence |
denotes |
The pattern of cerebral atrophy varied widely in the affected individuals. |
| T16 |
1044-1118 |
Sentence |
denotes |
The pattern of cerebral atrophy varied widely in the affected individuals. |
| TextSentencer_T17 |
1119-1295 |
Sentence |
denotes |
Neuropathologic features in 6 individuals included frontotemporal lobar degeneration with ubiquitin-positive neuronal cytoplasmic and intranuclear inclusions (FTLD-U with NII). |
| T17 |
1119-1295 |
Sentence |
denotes |
Neuropathologic features in 6 individuals included frontotemporal lobar degeneration with ubiquitin-positive neuronal cytoplasmic and intranuclear inclusions (FTLD-U with NII). |
| TextSentencer_T18 |
1296-1496 |
Sentence |
denotes |
PGRN analysis revealed a single base pair deletion in exon 2 (c.154delA), which caused a frameshift (p.Thr52HisfsX2) and, therefore, creation of a premature termination codon and a likely null allele. |
| T18 |
1296-1496 |
Sentence |
denotes |
PGRN analysis revealed a single base pair deletion in exon 2 (c.154delA), which caused a frameshift (p.Thr52HisfsX2) and, therefore, creation of a premature termination codon and a likely null allele. |
| TextSentencer_T19 |
1497-1509 |
Sentence |
denotes |
CONCLUSIONS: |
| T19 |
1497-1509 |
Sentence |
denotes |
CONCLUSIONS: |
| TextSentencer_T20 |
1510-1753 |
Sentence |
denotes |
In this large kindred, most affected individuals had clinical presentations that resembled Alzheimer disease or amnestic mild cognitive impairment associated with a mutation in PGRN and underlying FTLD-U with NII neuropathologic abnormalities. |
| T20 |
1510-1753 |
Sentence |
denotes |
In this large kindred, most affected individuals had clinical presentations that resembled Alzheimer disease or amnestic mild cognitive impairment associated with a mutation in PGRN and underlying FTLD-U with NII neuropathologic abnormalities. |
| TextSentencer_T21 |
1754-1904 |
Sentence |
denotes |
This finding is in distinct contrast to previously reported kindreds, in which clinical presentations have typically been within the spectrum of FTLD. |
| T21 |
1754-1904 |
Sentence |
denotes |
This finding is in distinct contrast to previously reported kindreds, in which clinical presentations have typically been within the spectrum of FTLD. |
| TextSentencer_T22 |
1905-1999 |
Sentence |
denotes |
The basis for the large difference in age at onset between generations requires further study. |
| T22 |
1905-1999 |
Sentence |
denotes |
The basis for the large difference in age at onset between generations requires further study. |